SEARCH

SEARCH BY CITATION

References

  • Akesson P, Sjoholm AG & Bjorck L (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271: 10811088.
  • Banks DJ, Porcella SF, Barbian KD, Beres SB, Philips LE, Voyich JM, DeLeo FR, Martin JM, Somerville GA & Musser JM (2004) Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis 190: 727738.
  • Beres SB, Sylva GL, Barbian KD et al. (2002) Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA 99: 1007810083.
  • Bessen D, Jones KF & Fischetti VA (1989) Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 169: 269283.
  • Bessen DE, Sotir CM, Readdy TL & Hollingshead SK (1996) Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 173: 896900.
  • Bessen DE, Izzo MW, Fiorentino TR, Caringal RM, Hollingshead SK & Beall B (1999) Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis 179: 627636.
  • Bessen DE, Carapetis JR, Beall B, Katz R, Hibble M, Currie BJ, Collingridge T, Izzo MW, Scaramuzzino DA & Sriprakash KS (2000) Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis 182: 11091116.
  • Caparon MG & Scott JR (1987) Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci USA 84: 86778681.
  • Chaussee MA, Callegari EA & Chaussee MS (2004) Rgg regulates growth phase-dependent expression of proteins associated with secondary metabolism and stress in Streptococcus pyogenes. J Bacteriol 186: 70917099.
  • Chaussee MS, Ajdic D & Ferretti JJ (1999) The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect Immun 67: 17151722.
  • Chaussee MS, Watson RO, Smoot JC & Musser JM (2001) Identification of Rgg-regulated exoproteins of Streptococcus pyogenes. Infect Immun 69: 822831.
  • Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U & Olsen A (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70: 66466651.
  • Engleberg NC, Heath A, Miller A, Rivera C & DiRita VJ (2001) Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 183: 10431054.
  • Engleberg NC, Heath A, Vardaman K & DiRita VJ (2004) Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun 72: 623628.
  • Federle MJ, McIver KS & Scott JR (1999) A response regulator that represses transcription of several virulence operons in the group A Streptococcus. J Bacteriol 181: 36493657.
  • Ferretti JJ, McShan WM, Ajdic D et al. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 98: 46584663.
  • Gozalbo D, Gil-Navarro I, Azorin I, Renau-Piqueras J, Martinez JP & Gil ML (1998) The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun 66: 20522059.
  • Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, Porcella SF, Federle MJ, Adams GJ, Scott JR & Musser JM (2002) Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci USA 99: 1385513860.
  • Heath A, DiRita VJ, Barg NL & Engleberg NC (1999) A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 67: 52985305.
  • Hoe NP, Kordari P, Cole R et al. (2000) Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis 182: 14251436.
  • Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, Dou SJ, Pan X, Nakashima K & Musser JM (2001) Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis 183: 633639.
  • Hoe NP, Ireland RM, DeLeo FR et al. (2002) Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci USA 99: 76467651.
  • Hughes TR, Marton MJ & Jones AR (2000) Functional discovery via a compendium of expression profiles. Cell 102: 109126.
  • Hynes WL & Tagg JR (1985) A simple plate assay for the detection of group A Streptococcus proteinase. J Microbiol Methods 4: 2531.
  • Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, Hamill RJ, Patti JM & Musser JM (1993) A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 15: 327346.
  • Kreikemeyer B, McIver KS & Podbielski A (2003) Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen–host interactions. Trends Microbiol 11: 224232.
  • Lei B, Mackie S, Lukomski S & Musser JM (2000) Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect Immun 68: 68076818.
  • Leimeister-Wachter M, Haffner C, Domann E, Goebel W & Chakraborty T (1990) Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of Listeria monocytogenes. Proc Natl Acad Sci USA 87: 83368340.
  • Levin JC & Wessels MR (1998) Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 30: 209219.
  • Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A & Musser JM (1997) Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 99: 25742580.
  • Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, Liu M, Dou SJ, Adams GG & Musser JM (2000) Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68: 535542.
  • McGregor KF, Spratt BG, Kalia A, Bennett A, Bilek N, Beall B & Bessen DE (2004) Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol 186: 42854294.
  • Modun B & Williams P (1999) The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun 67: 10861092.
  • Musser JM & Krause RM (1998) The Revival of Group A Streptococcal Diseases, with a Commentary on Staphylococcal Toxic Shock Syndrome. Emerging Infections (KrauseRM, ed), pp. 185218. Academic Press, New York.
  • Nakagawa I, Kurokawa K, Yamashita A et al. (2003) Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res 13: 10421055.
  • Reid SD, Green NM, Buss JK, Lei B & Musser JM (2001a) Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: population genetics, human serologic response, and gene transcription. Proc Natl Acad Sci USA 98: 75527557.
  • Reid SD, Hoe NP, Smoot LM & Musser JM (2001b) Group A Streptococcus: allelic variation, population genetics, and host–pathogen interactions. J Clin Invest 107: 393399.
  • Reid S, Montgomery A & Musser J (2004) Identification of srv, a PrfA-like regulator of group A Streptococcus that influences virulence. Infect Immun 72: 17991803.
  • Robbins JC, Spanier JG, Jones SJ, Simpson WJ & Cleary PP (1987) Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol 169: 56335640.
  • Schmidtchen A, Frick IM, Andersson E, Tapper H & Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46: 157168.
  • Simpson WJ & Cleary PP (1987) Expression of m type 12 protein by a group A Streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun 55: 24482455.
  • Smoot JC, Barbian KD, Van Gompel JJ et al. (2002) Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 99: 46684673.
  • Smoot LM, Smoot JC, Graham MR, Somerville GA, Sturdevant DE, Migliaccio CA, Sylva GL & Musser JM (2001) Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc Natl Acad Sci USA 98: 1041610421.
  • Spanier JG, Jones SJ & Cleary P (1984) Small DNA deletions creating avirulence in Streptococcus pyogenes. Science 225: 935938.
  • Stockbauer KE, Grigsby D, Pan X, Fu YX, Mejia LM, Cravioto A & Musser JM (1998) Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci USA 95: 31283133.
  • Tatusov RL, Galperin MY, Natale DA & Koonin EV (2000) The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res 28: 3336.
  • Voyich JM, Sturdevant DE, Braughton KR, Kobayashi SD, Lei B, Virtaneva K, Dorward DW, Musser JM & DeLeo FR (2003) Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 100: 19962001.